Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease
- 1 January 2001
- book chapter
- Published by Springer Nature
- Vol. 66, 81-107
- https://doi.org/10.1385/1-59259-148-5:81
Abstract
Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5, 8, 13, 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).Keywords
This publication has 0 references indexed in Scilit: